Aricept ODT

See also: Generic Aricept

Aricept ODT is a brand name of donepezil, approved by the FDA in the following formulation(s):

ARICEPT ODT (donepezil hydrochloride - tablet, orally disintegrating; oral)

• 
  Manufacturer: EISAI INC
  
  Approval date: October 18, 2004
  
  Strength(s): 10MG ^[RLD][AB], 5MG ^[AB]

Has a generic version of Aricept ODT been approved?

A generic version of Aricept ODT has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Aricept ODT and have been approved by the FDA:

donepezil hydrochloride tablet, orally disintegrating; oral

• 
  Manufacturer: BARR
  
  Approval date: November 26, 2010
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: May 10, 2011
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: May 10, 2011
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aricept ODT. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Rapidly disintegrable tablet containing polyvinyl alcohol
  Patent 7,727,548
  Issued: June 1, 2010
  Inventor(s): Morita; Yutaka & Yasui; Masanobu & Ohwaki; Takayuki & Tsushima; Yuki
  Assignee(s): Eisai R&D Management Co., Ltd.
  The present invention provides a quickly disintegrating tablet which has quick disintegrability and solubility in an oral cavity, and does not have uncomfortable tastes such as bitterness, has a small variation of a tablet physical property even in storage under a humidifying condition, and has substantially no change in a medicine content in the tablet and tablet appearance and which is superior in stability; and a manufacturing method of the tablet. That is, it provides: a quickly disintegrating tablet which is prepared by blending a medicine with a saccharide and polyvinyl alcohol, which has small variations of tablet weight, tablet hardness, tablet diameter and tablet thickness, and which is superior in medicine stability in the tablet; and a manufacturing method of the tablet.
  
  Patent expiration dates:
  
  
  • June 23, 2022
    
    ✓ 
    Patent use: ADMINISTRATION OF APPROVED PRODUCT FOR TREATMENT OF ALZHEIMER'S DISEASE
    ✓ 
    Drug product
  
  



• 
  Oral pharmaceutical preparations decreased in bitterness by masking
  Patent 7,727,552
  Issued: June 1, 2010
  Inventor(s): Ukai; Koji & Hrada; Tsutomu & Suzuki; Yasuyuki
  Assignee(s): Eisai R&D Management Co., Ltd.
  A composition of an oral medicine or an oral medicine which can prevent an unpleasant taste of the medicine is herein disclosed. It is granules, powders, syrups and the like which is prevented from an unpleasant taste, comprising a basic medicine having an unpleasant taste and an anionic polymer such as carrageenan.
  
  Patent expiration dates:
  
  
  • March 26, 2018
    
    ✓ 
    Drug product
  
  

See also...

• Aricept ODT Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Aricept ODT Consumer Information (Cerner Multum)
• Donepezil Consumer Information (Wolters Kluwer)
• Donepezil Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Donepezil Consumer Information (Cerner Multum)
• Donepezil Advanced Consumer Information (Micromedex)
• Donepezil Hydrochloride AHFS DI Monographs (ASHP)